ADC Therapeutics
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 274
- Market Cap
- $295.7M
- Introduction
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded b...
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- ADC Therapeutics S.A.
- Target Recruit Count
- 133
- Registration Number
- NCT02432235
- Locations
- 🇺🇸
Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
🇺🇸Froedtert Hospital/Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, United States
© Copyright 2024. All Rights Reserved by MedPath